ProCE Banner Activity

Key COVID-19 Studies Influencing My Practice Following IDWeek 2022

Slideset Download

Read expert faculty member summaries of the latest data on COVID-19 vaccines, risk factors and risk stratification, diagnostics, therapeutics, treatment of patients with immunocompromise, and long COVID.

Released: November 01, 2022

Share

Faculty

Gregory Huhn

Gregory Huhn, MD, MPHTM

Interim Chief, Division of Infectious Diseases
Senior Director of HIV Services
Cook County HIV Integrated Programs
Interim Medical Director, The RMR CORE Center
Professor, Division of Infectious Diseases
Rush University Medical Center
Chicago, IL

Princy N. Kumar

Princy N. Kumar, MD, FIDSA, MACP

Professor of Medicine and Microbiology
Chief, Division of Infectious Diseases and Tropical Medicine
Senior Associate Dean of Students
Georgetown University School of Medicine
Washington, DC

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by educational grants from

AstraZeneca

Gilead Sciences, Inc.

Merck Sharp & Dohme Corp.

Faculty Disclosure

Primary Author

Gregory Huhn, MD, MPHTM

Interim Chief, Division of Infectious Diseases
Senior Director of HIV Services
Cook County HIV Integrated Programs
Interim Medical Director, The RMR CORE Center
Professor, Division of Infectious Diseases
Rush University Medical Center
Chicago, IL

Gregory Huhn, MD, MPHTM: consultant/advisor/speaker: Gilead Sciences, Integritas, Janssen, Lilly, Merck, ViiV; researcher: Gilead Sciences, Janssen, Lilly, ViiV.

Princy N. Kumar, MD, FIDSA, MACP

Professor of Medicine and Microbiology
Chief, Division of Infectious Diseases and Tropical Medicine
Senior Associate Dean of Students
Georgetown University School of Medicine
Washington, DC

Princy N. Kumar, MD, FIDSA, MACP: consultant/advisor/speaker: Gilead Sciences, Johnson & Johnson, Merck, Theratechnologies, ViiV; researcher: American Gene Technologies, Gilead Sciences, GlaxoSmithKline, Merck; stock/stock options: Gilead, GlaxoSmithKline, Johnson & Johnson, Merck, Pfizer.